HEADER    IMMUNE SYSTEM/PEPTIDE INHIBITOR         12-OCT-99   1D5Z              
TITLE     X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDOMIMETIC AND  
TITLE    2 SEB                                                                  
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: PROTEIN (HLA CLASS II HISTOCOMPATIBILITY ANTIGEN);         
COMPND   3 CHAIN: A;                                                            
COMPND   4 FRAGMENT: DR ALPHA CHAIN, EXTRACELLULAR DOMAIN;                      
COMPND   5 SYNONYM: HLA-DR4;                                                    
COMPND   6 ENGINEERED: YES;                                                     
COMPND   7 MOL_ID: 2;                                                           
COMPND   8 MOLECULE: PROTEIN (HLA CLASS II HISTOCOMPATIBILITY ANTIGEN);         
COMPND   9 CHAIN: B;                                                            
COMPND  10 FRAGMENT: DR-4 BETA CHAIN, EXTRACELLULAR DOMAIN;                     
COMPND  11 SYNONYM: HLA-DR4;                                                    
COMPND  12 ENGINEERED: YES;                                                     
COMPND  13 MOL_ID: 3;                                                           
COMPND  14 MOLECULE: PROTEIN (ENTEROTOXIN TYPE B);                              
COMPND  15 CHAIN: C;                                                            
COMPND  16 SYNONYM: SEB, SUPERANTIGEN;                                          
COMPND  17 MOL_ID: 4;                                                           
COMPND  18 MOLECULE: PROTEIN (PEPTIDOMIMETIC INHIBITOR);                        
COMPND  19 CHAIN: D;                                                            
COMPND  20 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER;                          
SOURCE   6 EXPRESSION_SYSTEM_COMMON: FRUIT FLY;                                 
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 7227;                                       
SOURCE   8 MOL_ID: 2;                                                           
SOURCE   9 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE  10 ORGANISM_COMMON: HUMAN;                                              
SOURCE  11 ORGANISM_TAXID: 9606;                                                
SOURCE  12 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER;                          
SOURCE  13 EXPRESSION_SYSTEM_COMMON: FRUIT FLY;                                 
SOURCE  14 EXPRESSION_SYSTEM_TAXID: 7227;                                       
SOURCE  15 MOL_ID: 3;                                                           
SOURCE  16 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS AUREUS;                          
SOURCE  17 ORGANISM_TAXID: 1280;                                                
SOURCE  18 MOL_ID: 4;                                                           
SOURCE  19 SYNTHETIC: YES;                                                      
SOURCE  20 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED.               
KEYWDS    MHC CLASS II-SUPERANTIGEN COMPLEX, IMMUNE SYSTEM-PEPTIDE INHIBITOR    
KEYWDS   2 COMPLEX, PEPTIDOMIMETIC INHIBITOR                                    
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    A.SWAIN,R.CROWTHER,U.KAMMLOTT                                         
REVDAT   8   06-NOV-24 1D5Z    1       REMARK                                   
REVDAT   7   15-NOV-23 1D5Z    1       LINK   ATOM                              
REVDAT   6   20-SEP-23 1D5Z    1       REMARK                                   
REVDAT   5   31-MAY-23 1D5Z    1       LINK                                     
REVDAT   4   13-JUL-11 1D5Z    1       VERSN                                    
REVDAT   3   24-FEB-09 1D5Z    1       VERSN                                    
REVDAT   2   01-APR-03 1D5Z    1       JRNL                                     
REVDAT   1   28-JUN-00 1D5Z    0                                                
JRNL        AUTH   D.R.BOLIN,A.L.SWAIN,R.SARABU,S.J.BERTHEL,P.GILLESPIE,        
JRNL        AUTH 2 N.J.HUBY,R.MAKOFSKE,L.ORZECHOWSKI,A.PERROTTA,K.TOTH,         
JRNL        AUTH 3 J.P.COOPER,N.JIANG,F.FALCIONI,R.CAMPBELL,D.COX,D.GAIZBAND,   
JRNL        AUTH 4 C.J.BELUNIS,D.VIDOVIC,K.ITO,R.CROWTHER,U.KAMMLOTT,X.ZHANG,   
JRNL        AUTH 5 R.PALERMO,D.WEBER,J.GUENOT,Z.NAGY,G.L.OLSON                  
JRNL        TITL   PEPTIDE AND PEPTIDE MIMETIC INHIBITORS OF ANTIGEN            
JRNL        TITL 2 PRESENTATION BY HLA-DR CLASS II MHC MOLECULES. DESIGN,       
JRNL        TITL 3 STRUCTURE-ACTIVITY RELATIONSHIPS, AND X-RAY CRYSTAL          
JRNL        TITL 4 STRUCTURES.                                                  
JRNL        REF    J.MED.CHEM.                   V.  43  2135 2000              
JRNL        REFN                   ISSN 0022-2623                               
JRNL        PMID   10841792                                                     
JRNL        DOI    10.1021/JM000034H                                            
REMARK   2                                                                      
REMARK   2 RESOLUTION.    2.00 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : CNS 0.9                                              
REMARK   3   AUTHORS     : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-              
REMARK   3               : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,              
REMARK   3               : READ,RICE,SIMONSON,WARREN                            
REMARK   3                                                                      
REMARK   3  REFINEMENT TARGET : NULL                                            
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 19.45                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   DATA CUTOFF HIGH         (ABS(F)) : 374134.830                     
REMARK   3   DATA CUTOFF LOW          (ABS(F)) : 0.0000                         
REMARK   3   COMPLETENESS (WORKING+TEST)   (%) : 94.1                           
REMARK   3   NUMBER OF REFLECTIONS             : 50725                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
REMARK   3   R VALUE            (WORKING SET) : 0.234                           
REMARK   3   FREE R VALUE                     : 0.265                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 10.100                          
REMARK   3   FREE R VALUE TEST SET COUNT      : 5123                            
REMARK   3   ESTIMATED ERROR OF FREE R VALUE  : 0.004                           
REMARK   3                                                                      
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
REMARK   3   TOTAL NUMBER OF BINS USED           : 6                            
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 2.00                         
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 2.13                         
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : 88.10                        
REMARK   3   REFLECTIONS IN BIN    (WORKING SET) : 6982                         
REMARK   3   BIN R VALUE           (WORKING SET) : 0.2530                       
REMARK   3   BIN FREE R VALUE                    : 0.2960                       
REMARK   3   BIN FREE R VALUE TEST SET SIZE  (%) : 10.60                        
REMARK   3   BIN FREE R VALUE TEST SET COUNT     : 827                          
REMARK   3   ESTIMATED ERROR OF BIN FREE R VALUE : 0.010                        
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 4904                                    
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 0                                       
REMARK   3   SOLVENT ATOMS            : 137                                     
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : 6.80                           
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 20.10                          
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : 1.01000                                              
REMARK   3    B22 (A**2) : 3.80000                                              
REMARK   3    B33 (A**2) : -4.81000                                             
REMARK   3    B12 (A**2) : 0.00000                                              
REMARK   3    B13 (A**2) : 0.00000                                              
REMARK   3    B23 (A**2) : 0.00000                                              
REMARK   3                                                                      
REMARK   3  ESTIMATED COORDINATE ERROR.                                         
REMARK   3   ESD FROM LUZZATI PLOT        (A) : 0.26                            
REMARK   3   ESD FROM SIGMAA              (A) : 0.16                            
REMARK   3   LOW RESOLUTION CUTOFF        (A) : 5.00                            
REMARK   3                                                                      
REMARK   3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR.                         
REMARK   3   ESD FROM C-V LUZZATI PLOT    (A) : 0.31                            
REMARK   3   ESD FROM C-V SIGMAA          (A) : 0.21                            
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.                                   
REMARK   3   BOND LENGTHS                 (A) : 0.007                           
REMARK   3   BOND ANGLES            (DEGREES) : 1.400                           
REMARK   3   DIHEDRAL ANGLES        (DEGREES) : 25.80                           
REMARK   3   IMPROPER ANGLES        (DEGREES) : 0.820                           
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL MODEL : RESTRAINED                                
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA                
REMARK   3   MAIN-CHAIN BOND              (A**2) : 1.310 ; 1.500                
REMARK   3   MAIN-CHAIN ANGLE             (A**2) : 2.020 ; 2.000                
REMARK   3   SIDE-CHAIN BOND              (A**2) : 1.950 ; 2.000                
REMARK   3   SIDE-CHAIN ANGLE             (A**2) : 2.870 ; 2.500                
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED : FLAT MODEL                                           
REMARK   3   KSOL        : 0.39                                                 
REMARK   3   BSOL        : 33.87                                                
REMARK   3                                                                      
REMARK   3  NCS MODEL : NULL                                                    
REMARK   3                                                                      
REMARK   3  NCS RESTRAINTS.                         RMS   SIGMA/WEIGHT          
REMARK   3   GROUP  1  POSITIONAL            (A) : NULL  ; NULL                 
REMARK   3   GROUP  1  B-FACTOR           (A**2) : NULL  ; NULL                 
REMARK   3                                                                      
REMARK   3  PARAMETER FILE  1  : NULL                                           
REMARK   3  TOPOLOGY FILE  1   : NULL                                           
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 1D5Z COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-OCT-99.                  
REMARK 100 THE DEPOSITION ID IS D_1000009825.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 01-JAN-94                          
REMARK 200  TEMPERATURE           (KELVIN) : 113                                
REMARK 200  PH                             : 7.4                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : NSLS                               
REMARK 200  BEAMLINE                       : X4A                                
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.9686                             
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : IMAGE PLATE                        
REMARK 200  DETECTOR MANUFACTURER          : FUJI                               
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : DENZO                              
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK                          
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 51927                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 2.000                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 20.000                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL                               
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 96.2                               
REMARK 200  DATA REDUNDANCY                : NULL                               
REMARK 200  R MERGE                    (I) : 0.06700                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : NULL                               
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : NULL                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : NULL                               
REMARK 200  DATA REDUNDANCY IN SHELL       : NULL                               
REMARK 200  R MERGE FOR SHELL          (I) : NULL                               
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : NULL                               
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: AMORE                                                 
REMARK 200 STARTING MODEL: PDB ID CODE 1D5M                                     
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 54.38                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.4                                   
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21                       
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X+1/2,-Y,Z+1/2                                         
REMARK 290       3555   -X,Y+1/2,-Z+1/2                                         
REMARK 290       4555   X+1/2,-Y+1/2,-Z                                         
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000       39.17150            
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000       50.08750            
REMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       50.08400            
REMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000       50.08750            
REMARK 290   SMTRY1   4  1.000000  0.000000  0.000000       39.17150            
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000       50.08400            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC                        
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D                            
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 400                                                                      
REMARK 400 COMPOUND                                                             
REMARK 400 INHIBITOR WAS BOUND TO MHC; SUBSEQUENTLY COMPLEX WITH SEB WAS FORMED 
REMARK 400                                                                      
REMARK 400 THE ACE-ALC-ARG-ALA-ODA-SER-LEU-NH2 IS PEPTIDE-LIKE, A MEMBER OF     
REMARK 400 INHIBITOR CLASS.                                                     
REMARK 400                                                                      
REMARK 400  GROUP: 1                                                            
REMARK 400   NAME: ACE-ALC-ARG-ALA-ODA-SER-LEU-NH2                              
REMARK 400   CHAIN: D                                                           
REMARK 400   COMPONENT_1: PEPTIDE LIKE POLYMER                                  
REMARK 400   DESCRIPTION: NULL                                                  
REMARK 465                                                                      
REMARK 465 MISSING RESIDUES                                                     
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                       
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                
REMARK 465                                                                      
REMARK 465   M RES C SSSEQI                                                     
REMARK 465     ILE A     1                                                      
REMARK 465     LYS A     2                                                      
REMARK 465     ASP A   181                                                      
REMARK 465     LYS B   105                                                      
REMARK 465     THR B   106                                                      
REMARK 465     GLN B   107                                                      
REMARK 465     PRO B   108                                                      
REMARK 465     LEU B   109                                                      
REMARK 465     GLN B   110                                                      
REMARK 465     HIS B   111                                                      
REMARK 465     HIS B   112                                                      
REMARK 465     ASN B   113                                                      
REMARK 465     ARG B   191                                                      
REMARK 465     SER B   192                                                      
REMARK 465     GLU C     1                                                      
REMARK 465     THR C    99                                                      
REMARK 465     ASN C   100                                                      
REMARK 465     ASP C   101                                                      
REMARK 465     ILE C   102                                                      
REMARK 465     ASN C   103                                                      
REMARK 465     SER C   104                                                      
REMARK 465     HIS C   105                                                      
REMARK 465     GLN C   106                                                      
REMARK 465     THR C   107                                                      
REMARK 465     ASP C   108                                                      
REMARK 465     LYS C   238                                                      
REMARK 465     LYS C   239                                                      
REMARK 470                                                                      
REMARK 470 MISSING ATOM                                                         
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;           
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;          
REMARK 470 I=INSERTION CODE):                                                   
REMARK 470   M RES CSSEQI  ATOMS                                                
REMARK 470     ARG B  55    CG   CD   NE   CZ   NH1  NH2                        
REMARK 470     LYS C 109    CG   CD   CE   NZ                                   
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES                                       
REMARK 500                                                                      
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)              
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
REMARK 500                                                                      
REMARK 500  M RES CSSEQI ATM1   ATM2   ATM3                                     
REMARK 500    ODA D 807   CA  -  C   -  N   ANGL. DEV. =  19.9 DEGREES          
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    THR A 113      147.61   -170.28                                   
REMARK 500    ASN B  19       72.70     42.90                                   
REMARK 500    HIS B  33     -109.05     71.34                                   
REMARK 500    THR B  90      -72.77   -127.28                                   
REMARK 500    ASP C  42     -179.02   -173.50                                   
REMARK 500    PHE C  44      -64.69    -99.58                                   
REMARK 500    LEU C  58       19.73   -164.48                                   
REMARK 500    LYS C  97     -122.90    -95.34                                   
REMARK 500    ARG C 110     -169.97    179.22                                   
REMARK 500    ASN C 179     -150.58   -143.89                                   
REMARK 500    GLU C 193       17.86     54.26                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS                                         
REMARK 500                                                                      
REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH          
REMARK 500 CIS AND TRANS CONFORMATION.  CIS BONDS, IF ANY, ARE LISTED           
REMARK 500 ON CISPEP RECORDS.  TRANS IS DEFINED AS 180 +/- 30 AND               
REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES.                                  
REMARK 500                                 MODEL     OMEGA                      
REMARK 500 ODA D  807     SER D  808                 -127.20                    
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY                                       
REMARK 500                                                                      
REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY                       
REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER                 
REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME;                     
REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;                            
REMARK 500 I=INSERTION CODE).                                                   
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        ANGLE                                           
REMARK 500    ODA D 807         32.47                                           
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF PROTEIN                
REMARK 800  (PEPTIDOMIMETIC INHIBITOR)                                          
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1D5M   RELATED DB: PDB                                   
REMARK 900 RELATED ID: 1D5X   RELATED DB: PDB                                   
REMARK 900 RELATED ID: 1D6E   RELATED DB: PDB                                   
DBREF  1D5Z A    1   181  UNP    P01903   HA2R_HUMAN      26    206             
DBREF  1D5Z B    1   192  UNP    P13760   HB2H_HUMAN      30    221             
DBREF  1D5Z C    1   239  UNP    P01552   ETXB_STAAU      28    266             
DBREF  1D5Z D  803   810  PDB    1D5Z     1D5Z           803    810             
SEQRES   1 A  181  ILE LYS GLU GLU HIS VAL ILE ILE GLN ALA GLU PHE TYR          
SEQRES   2 A  181  LEU ASN PRO ASP GLN SER GLY GLU PHE MET PHE ASP PHE          
SEQRES   3 A  181  ASP GLY ASP GLU ILE PHE HIS VAL ASP MET ALA LYS LYS          
SEQRES   4 A  181  GLU THR VAL TRP ARG LEU GLU GLU PHE GLY ARG PHE ALA          
SEQRES   5 A  181  SER PHE GLU ALA GLN GLY ALA LEU ALA ASN ILE ALA VAL          
SEQRES   6 A  181  ASP LYS ALA ASN LEU GLU ILE MET THR LYS ARG SER ASN          
SEQRES   7 A  181  TYR THR PRO ILE THR ASN VAL PRO PRO GLU VAL THR VAL          
SEQRES   8 A  181  LEU THR ASN SER PRO VAL GLU LEU ARG GLU PRO ASN VAL          
SEQRES   9 A  181  LEU ILE CYS PHE ILE ASP LYS PHE THR PRO PRO VAL VAL          
SEQRES  10 A  181  ASN VAL THR TRP LEU ARG ASN GLY LYS PRO VAL THR THR          
SEQRES  11 A  181  GLY VAL SER GLU THR VAL PHE LEU PRO ARG GLU ASP HIS          
SEQRES  12 A  181  LEU PHE ARG LYS PHE HIS TYR LEU PRO PHE LEU PRO SER          
SEQRES  13 A  181  THR GLU ASP VAL TYR ASP CYS ARG VAL GLU HIS TRP GLY          
SEQRES  14 A  181  LEU ASP GLU PRO LEU LEU LYS HIS TRP GLU PHE ASP              
SEQRES   1 B  192  GLY ASP THR ARG PRO ARG PHE LEU GLU GLN VAL LYS HIS          
SEQRES   2 B  192  GLU CYS HIS PHE PHE ASN GLY THR GLU ARG VAL ARG PHE          
SEQRES   3 B  192  LEU ASP ARG TYR PHE TYR HIS GLN GLU GLU TYR VAL ARG          
SEQRES   4 B  192  PHE ASP SER ASP VAL GLY GLU TYR ARG ALA VAL THR GLU          
SEQRES   5 B  192  LEU GLY ARG PRO ASP ALA GLU TYR TRP ASN SER GLN LYS          
SEQRES   6 B  192  ASP LEU LEU GLU GLN LYS ARG ALA ALA VAL ASP THR TYR          
SEQRES   7 B  192  CYS ARG HIS ASN TYR GLY VAL GLY GLU SER PHE THR VAL          
SEQRES   8 B  192  GLN ARG ARG VAL TYR PRO GLU VAL THR VAL TYR PRO ALA          
SEQRES   9 B  192  LYS THR GLN PRO LEU GLN HIS HIS ASN LEU LEU VAL CYS          
SEQRES  10 B  192  SER VAL ASN GLY PHE TYR PRO GLY SER ILE GLU VAL ARG          
SEQRES  11 B  192  TRP PHE ARG ASN GLY GLN GLU GLU LYS THR GLY VAL VAL          
SEQRES  12 B  192  SER THR GLY LEU ILE GLN ASN GLY ASP TRP THR PHE GLN          
SEQRES  13 B  192  THR LEU VAL MET LEU GLU THR VAL PRO ARG SER GLY GLU          
SEQRES  14 B  192  VAL TYR THR CYS GLN VAL GLU HIS PRO SER LEU THR SER          
SEQRES  15 B  192  PRO LEU THR VAL GLU TRP ARG ALA ARG SER                      
SEQRES   1 C  239  GLU SER GLN PRO ASP PRO LYS PRO ASP GLU LEU HIS LYS          
SEQRES   2 C  239  SER SER LYS PHE THR GLY LEU MET GLU ASN MET LYS VAL          
SEQRES   3 C  239  LEU TYR ASP ASP ASN HIS VAL SER ALA ILE ASN VAL LYS          
SEQRES   4 C  239  SER ILE ASP GLN PHE LEU TYR PHE ASP LEU ILE TYR SER          
SEQRES   5 C  239  ILE LYS ASP THR LYS LEU GLY ASN TYR ASP ASN VAL ARG          
SEQRES   6 C  239  VAL GLU PHE LYS ASN LYS ASP LEU ALA ASP LYS TYR LYS          
SEQRES   7 C  239  ASP LYS TYR VAL ASP VAL PHE GLY ALA ASN TYR TYR TYR          
SEQRES   8 C  239  GLN CYS TYR PHE SER LYS LYS THR ASN ASP ILE ASN SER          
SEQRES   9 C  239  HIS GLN THR ASP LYS ARG LYS THR CYS MET TYR GLY GLY          
SEQRES  10 C  239  VAL THR GLU HIS ASN GLY ASN GLN LEU ASP LYS TYR ARG          
SEQRES  11 C  239  SER ILE THR VAL ARG VAL PHE GLU ASP GLY LYS ASN LEU          
SEQRES  12 C  239  LEU SER PHE ASP VAL GLN THR ASN LYS LYS LYS VAL THR          
SEQRES  13 C  239  ALA GLN GLU LEU ASP TYR LEU THR ARG HIS TYR LEU VAL          
SEQRES  14 C  239  LYS ASN LYS LYS LEU TYR GLU PHE ASN ASN SER PRO TYR          
SEQRES  15 C  239  GLU THR GLY TYR ILE LYS PHE ILE GLU ASN GLU ASN SER          
SEQRES  16 C  239  PHE TRP TYR ASP MET MET PRO ALA PRO GLY ASP LYS PHE          
SEQRES  17 C  239  ASP GLN SER LYS TYR LEU MET MET TYR ASN ASP ASN LYS          
SEQRES  18 C  239  MET VAL ASP SER LYS ASP VAL LYS ILE GLU VAL TYR LEU          
SEQRES  19 C  239  THR THR LYS LYS LYS                                          
SEQRES   1 D    8  ACE ALC ARG ALA ODA SER LEU NH2                              
MODRES 1D5Z ALC D  804  ALA  2-AMINO-3-CYCLOHEXYL-PROPIONIC ACID                
HET    ACE  D 803       3                                                       
HET    ALC  D 804      11                                                       
HET    ODA  D 807      16                                                       
HET    NH2  D 810       1                                                       
HETNAM     ACE ACETYL GROUP                                                     
HETNAM     ALC 2-AMINO-3-CYCLOHEXYL-PROPIONIC ACID                              
HETNAM     ODA 9-AMINO-6,10-DIOXO-OCTAHYDRO-PYRIDAZINO[1,2-A][1,                
HETNAM   2 ODA  2]DIAZEPINE-1-CARBOXYLIC ACID                                   
HETNAM     NH2 AMINO GROUP                                                      
FORMUL   4  ACE    C2 H4 O                                                      
FORMUL   4  ALC    C9 H17 N O2                                                  
FORMUL   4  ODA    C10 H15 N3 O4                                                
FORMUL   4  NH2    H2 N                                                         
FORMUL   5  HOH   *137(H2 O)                                                    
HELIX    1   1 GLU A   47  ALA A   52  1                                   6    
HELIX    2   2 GLN A   57  SER A   77  1                                  21    
HELIX    3   3 THR B   51  LEU B   53  5                                   3    
HELIX    4   4 GLY B   54  SER B   63  1                                  10    
HELIX    5   5 GLN B   64  TYR B   78  1                                  15    
HELIX    6   6 TYR B   78  GLU B   87  1                                  10    
HELIX    7   7 SER B   88  THR B   90  5                                   3    
HELIX    8   8 LYS C   13  LYS C   16  5                                   4    
HELIX    9   9 MET C   21  VAL C   26  1                                   6    
HELIX   10  10 LEU C   27  ASP C   29  5                                   3    
HELIX   11  11 ASN C   70  ASP C   79  1                                  10    
HELIX   12  12 ALA C  157  LYS C  173  1                                  17    
HELIX   13  13 ASP C  209  MET C  215  1                                   7    
HELIX   14  14 MET C  216  ASN C  220  5                                   5    
SHEET    1   A 8 GLU A  40  TRP A  43  0                                        
SHEET    2   A 8 ASP A  29  ASP A  35 -1  O  HIS A  33   N  VAL A  42           
SHEET    3   A 8 SER A  19  PHE A  26 -1  O  PHE A  22   N  VAL A  34           
SHEET    4   A 8 HIS A   5  ASN A  15 -1  N  ILE A   8   O  ASP A  25           
SHEET    5   A 8 PHE B   7  PHE B  18 -1  O  PHE B   7   N  ASN A  15           
SHEET    6   A 8 ARG B  23  TYR B  32 -1  O  ARG B  23   N  PHE B  18           
SHEET    7   A 8 GLU B  35  ASP B  41 -1  O  GLU B  35   N  TYR B  32           
SHEET    8   A 8 TYR B  47  ALA B  49 -1  N  ARG B  48   O  ARG B  39           
SHEET    1   B 4 GLU A  88  THR A  93  0                                        
SHEET    2   B 4 ASN A 103  PHE A 112 -1  N  ILE A 106   O  LEU A  92           
SHEET    3   B 4 PHE A 145  PHE A 153 -1  N  PHE A 145   O  PHE A 112           
SHEET    4   B 4 SER A 133  GLU A 134 -1  O  SER A 133   N  TYR A 150           
SHEET    1   C 4 GLU A  88  THR A  93  0                                        
SHEET    2   C 4 ASN A 103  PHE A 112 -1  N  ILE A 106   O  LEU A  92           
SHEET    3   C 4 PHE A 145  PHE A 153 -1  N  PHE A 145   O  PHE A 112           
SHEET    4   C 4 LEU A 138  PRO A 139 -1  N  LEU A 138   O  ARG A 146           
SHEET    1   D 4 LYS A 126  VAL A 128  0                                        
SHEET    2   D 4 ASN A 118  ARG A 123 -1  O  TRP A 121   N  VAL A 128           
SHEET    3   D 4 VAL A 160  GLU A 166 -1  O  ASP A 162   N  LEU A 122           
SHEET    4   D 4 LEU A 174  GLU A 179 -1  O  LEU A 174   N  VAL A 165           
SHEET    1   E 4 GLU B  98  PRO B 103  0                                        
SHEET    2   E 4 LEU B 115  PHE B 122 -1  N  VAL B 116   O  TYR B 102           
SHEET    3   E 4 PHE B 155  LEU B 161 -1  N  PHE B 155   O  PHE B 122           
SHEET    4   E 4 VAL B 142  SER B 144 -1  O  VAL B 143   N  MET B 160           
SHEET    1   F 4 GLU B  98  PRO B 103  0                                        
SHEET    2   F 4 LEU B 115  PHE B 122 -1  N  VAL B 116   O  TYR B 102           
SHEET    3   F 4 PHE B 155  LEU B 161 -1  N  PHE B 155   O  PHE B 122           
SHEET    4   F 4 ILE B 148  GLN B 149 -1  N  ILE B 148   O  GLN B 156           
SHEET    1   G 4 GLN B 136  GLU B 138  0                                        
SHEET    2   G 4 GLU B 128  ARG B 133 -1  O  TRP B 131   N  GLU B 138           
SHEET    3   G 4 VAL B 170  GLU B 176 -1  O  THR B 172   N  PHE B 132           
SHEET    4   G 4 LEU B 184  ARG B 189 -1  N  LEU B 184   O  VAL B 175           
SHEET    1   H 3 VAL C  33  VAL C  38  0                                        
SHEET    2   H 3 VAL C  82  GLY C  86 -1  N  VAL C  82   O  VAL C  38           
SHEET    3   H 3 VAL C 118  GLU C 120 -1  O  THR C 119   N  ASP C  83           
SHEET    1   I 3 ASP C  48  SER C  52  0                                        
SHEET    2   I 3 ASN C  63  GLU C  67 -1  N  VAL C  64   O  TYR C  51           
SHEET    3   I 3 LYS C 111  TYR C 115  1  O  THR C 112   N  ARG C  65           
SHEET    1   J 5 LYS C 141  LYS C 152  0                                        
SHEET    2   J 5 GLN C 125  GLU C 138 -1  N  LEU C 126   O  ASN C 151           
SHEET    3   J 5 VAL C 228  THR C 236  1  N  ILE C 230   O  THR C 133           
SHEET    4   J 5 TYR C 182  GLU C 191 -1  N  GLU C 183   O  THR C 235           
SHEET    5   J 5 ASN C 194  ASP C 199 -1  O  ASN C 194   N  GLU C 191           
SHEET    1   K 2 LYS C 154  THR C 156  0                                        
SHEET    2   K 2 MET C 222  ASP C 224 -1  N  VAL C 223   O  VAL C 155           
SSBOND   1 CYS A  107    CYS A  163                          1555   1555  2.04  
SSBOND   2 CYS B   15    CYS B   79                          1555   1555  2.06  
SSBOND   3 CYS B  117    CYS B  173                          1555   1555  2.03  
SSBOND   4 CYS C   93    CYS C  113                          1555   1555  2.05  
LINK         C   ACE D 803                 N   ALC D 804     1555   1555  1.34  
LINK         C   ALC D 804                 N   ARG D 805     1555   1555  1.31  
LINK         C   ALA D 806                 N   ODA D 807     1555   1555  1.32  
LINK         C   ODA D 807                 N   SER D 808     1555   1555  1.33  
CISPEP   1 ASN A   15    PRO A   16          0        -0.17                     
CISPEP   2 THR A  113    PRO A  114          0         0.30                     
CISPEP   3 TYR B  123    PRO B  124          0         0.13                     
SITE     1 AC1 24 GLN A   9  GLU A  11  PHE A  24  PHE A  32                    
SITE     2 AC1 24 TRP A  43  SER A  53  PHE A  54  ASN A  62                    
SITE     3 AC1 24 VAL A  65  ASP A  66  ASN A  69  GLU A 179                    
SITE     4 AC1 24 HIS B  13  TYR B  30  TYR B  47  TRP B  61                    
SITE     5 AC1 24 LEU B  67  LYS B  71  THR B  77  TYR B  78                    
SITE     6 AC1 24 HIS B  81  ASN B  82  VAL B  85  HOH D 927                    
CRYST1   78.343  100.168  100.175  90.00  90.00  90.00 P 21 21 21    4          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.012764  0.000000  0.000000        0.00000                         
SCALE2      0.000000  0.009983  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.009983        0.00000